Posts Tagged ‘032’
COVID-19 impact on opioid overdose after jail release in Massachusetts
Release from incarceration is a high-risk period for opioid overdose. Concern about COVID-19 spread in jails led to early releases; it is unknown whether pandemic era releases of persons with opioid use disorder (OUD) contributed to increases in community overdose rates. Observational data compared overdose rates three months after release among jailed persons with OUD…
Read More“And Then COVID Hits”: A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19
ils in Massachusetts are among the first nationwide to provide correctional populations with medications to treat opioid use disorder (MOUD). The COVID-19 pandemic caused jails to pivot and adapt MOUD programming. To facilitate continued access to MOUD, both during incarceration and also at community reentry, jail staff quickly implemented changes in MOUD regulations and dosing…
Read MoreJail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts
This study summarizes qualitative findings about reentry programming to support medications for opioid use disorder (MOUD) treatment continuity in the community upon release from jail. Interviews were completed in 2019 in the early implementation phase of seven jail’s MOUD programs.
Read MoreMedication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers
A qualitative study of big data and the opioid epidemic: recommendations for data governance
Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives
Uncommon and preventable: Perceptions of diversion of MOUD in jail
COVID-19 and treating incarcerated populations for opioid use disorder
Offering Buprenorphine Prior to Release from Jail May Reduce Recidivism
Findings from JCOIN’s Massachusetts Research Hub Individuals leaving incarceration with opioid use disorder (OUD) are at a high risk for overdose, recidivism, and adverse health outcomes. Providing medication for opioid use disorder (MOUD) prior to incarceration and post-release is effective in reducing negative outcomes. Existing studies tend to examine how the use of methadone and/or…
Read MoreMassachusetts Justice Community Opioid Innovation Network (MassJCOIN)
The goal of this study is to conduct a Type 1 hybrid effectiveness-implementation study of seven jails in Massachusetts that deliver all FDA-approved MOUDs (naltrexone, buprenorphine, methadone) to produce findings with implications for policies for OUD in criminal justice settings. This research will focus on (1) post-release recidivism, overdoses, and MOUD initiation, engagement, and retention,…
Read More